BEXIMCO PHARMACEUTIC

BXPHARMA
End-of-day quote. End-of-day quote  - 11/29
200.4BDT -2.58%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals
Beximco Pharmaceuticals Limited (BPL) is engaged in the manufacturing and marketing of generic pharmaceuticals formulation products, including intravenous fluids and active pharmaceutical ingredients (APIs). The Company also provides contract manufacturing services. The Company produces approximately 300 generic medicines, which are available in over 500 different presentations and the portfolio encompasses various key therapeutic categories, including antibiotics, analgesics, anti-diabetic, respiratory, cardiovascular, central nervous system, dermatology and gastrointestinal. Its product categories also include anti-infectives, musculoskeletal, oncology, respiratory, skin care, vitamins and minerals supplement, and others. The Company's products include Acifix, Femzole, Q-Rash, Tamona, Taverin, Tobasol, IcyKool Cream, Intracef, Gastalfet, Iprasol, Calorate, Gentosep and others. BPL's products are sold in domestic and international markets.
Sales per Business
20192020
Pharmaceutical Formulations and Active Pharmaceutical Ingredients22 816.60100%25 611.90100%
BDT in Million
Sales per region
20192020
Bangladesh22 816.60100%25 611.90100%
BDT in Million
Managers
Name Title
Nazmul Hassan Chief Executive Officer, Director & MD
Ali Nawaz Chief Financial Officer
Ahmed Sohail Fasihur Rahman Chairman
Selina Akter Executive Director-Medical Affairs Department
Rabbur Reza Chief Operating Officer
Mamtaz Uddin Ahmed Independent Non-Executive Director
Mohammad Ibraheem Hosein Khan Independent Director
Ahmed Salman Fasiur Rahman Vice Chairman
Iqbal Ahmed Director
Osman Kaiser Chowdhury Director
Shareholders
Name Equities %
Norges Bank Investment Management 14,524,404 3.26%
East Capital Financial Services AB 3,079,410 0.69%
BlackRock Fund Advisors 1,764,419 0.40%
Legal & General Investment Management Ltd. 1,663,079 0.37%
Franklin Templeton Investments (ME) Ltd. 1,420,358 0.32%
Tundra Fonder AB 1,000,000 0.22%
Russell Investments Ltd. 998,671 0.22%
Parametric Portfolio Associates LLC 207,136 0.046%
Exchange Traded Concepts LLC 132,921 0.030%
Banor Capital Ltd. 83,883 0.019%
Company contact information
Beximco Pharmaceuticals Ltd.
17 Dhanmondi R/A
House No. 17
Road No. 2
Dhaka 1205

Phone : +880.2.58611891
Fax : +880.2.58613470
Web : http://www.beximco-pharma.com
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
BEXIMCO PHARMACEUTICALS LIMITED4.00%1 114
JOHNSON & JOHNSON1.16%419 109
ROCHE HOLDING AG16.05%336 162
PFIZER, INC.42.35%303 095
NOVO NORDISK A/S67.00%247 254
ELI LILLY AND COMPANY50.93%236 049
ABBVIE INC.8.74%205 976
MERCK & CO., INC.-8.45%199 954
NOVARTIS AG-10.68%181 102
ASTRAZENECA PLC14.24%173 523
BRISTOL-MYERS SQUIBB COMPANY-11.91%125 477
SANOFI8.78%120 755
AMGEN INC.-11.50%113 267
GLAXOSMITHKLINE PLC13.64%100 759
CHUGAI PHARMACEUTICAL CO., LTD.-30.95%56 933
JIANGSU HENGRUI MEDICINE CO., LTD.-45.00%52 191
BAYER AG-5.89%50 628
DAIICHI SANKYO COMPANY, LIMITED-17.62%49 746
TAKEDA PHARMACEUTICAL COMPANY LIMITED-18.11%43 512
ASTELLAS PHARMA INC.15.21%30 934
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY39.55%23 703
Brand Portfolio
» More brands of Beximco Pharmaceuticals Limited